Evaluation of HPV E6/E7 mRNA Detection in Clinically Suspected Cases of Cervical Cancer with Abnormal Cytology: Time to Upgrade the Screening Protocols

Background  Human papillomavirus (HPV) E6/E7 mRNA tests determine the oncogenic activity of the virus and represent a good clinical biomarker for predicting the risk of cervical cancer. So, the present study was conducted to know the role of HPV E6/E7 mRNA as a predictive biomarker for cervical carc...

Descripción completa

Detalles Bibliográficos
Autores principales: Sharma, Bhawna, Lakhanpal, Vikas, Singh, Kanwardeep, Oberoi, Loveena, Bedi, Preet Kamal, Devi, Pushpa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Thieme Medical and Scientific Publishers Pvt. Ltd. 2022
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9473935/
https://www.ncbi.nlm.nih.gov/pubmed/36119422
http://dx.doi.org/10.1055/s-0042-1748919

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9473935/
https://www.ncbi.nlm.nih.gov/pubmed/36119422
http://dx.doi.org/10.1055/s-0042-1748919

Ejemplares similares